Proteo Competitors

Proteo (OTCMKTS:PTEO) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Proteo and (DDXS), as provided by MarketBeat.

Profitability

This table compares Proteo and (DDXS)'s net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Proteo and (DDXS)'s top-line revenue, earnings per share and valuation.

Proteo (OTCMKTS:PTEO) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Proteo and (TNGN), as provided by MarketBeat.

Valuation and Earnings

This table compares Proteo and (TNGN)'s top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Proteo and (TNGN)'s net margins, return on equity and return on assets.

Abattis Bioceuticals (OTCMKTS:ATTBF) and Proteo (OTCMKTS:PTEO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Profitability

This table compares Abattis Bioceuticals and Proteo's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and recommmendations for Abattis Bioceuticals and Proteo, as reported by MarketBeat.

Valuation and Earnings

This table compares Abattis Bioceuticals and Proteo's gross revenue, earnings per share and valuation.

ADiTx Therapeutics (NASDAQ:ADTX) and Proteo (OTCMKTS:PTEO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Profitability

This table compares ADiTx Therapeutics and Proteo's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and recommmendations for ADiTx Therapeutics and Proteo, as reported by MarketBeat.

Valuation and Earnings

This table compares ADiTx Therapeutics and Proteo's gross revenue, earnings per share and valuation.

Summary

ADiTx Therapeutics beats Proteo on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Proteo (OTCMKTS:PTEO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of current ratings for Algernon Pharmaceuticals and Proteo, as reported by MarketBeat.com.

Profitability

This table compares Algernon Pharmaceuticals and Proteo's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Algernon Pharmaceuticals and Proteo's gross revenue, earnings per share and valuation.

Almirall (OTCMKTS:LBTSF) and Proteo (OTCMKTS:PTEO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Almirall and Proteo, as provided by MarketBeat.

Profitability

This table compares Almirall and Proteo's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Almirall and Proteo's top-line revenue, earnings per share and valuation.

Summary

Almirall beats Proteo on 1 of the 1 factors compared between the two stocks.